Buch, Englisch, 472 Seiten, Format (B × H): 164 mm x 243 mm, Gewicht: 821 g
Volume 35
Buch, Englisch, 472 Seiten, Format (B × H): 164 mm x 243 mm, Gewicht: 821 g
Reihe: Specialist Periodical Reports
ISBN: 978-0-85404-247-0
Verlag: Royal Society of Chemistry
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Chapter 1: Amino Acids;
1: Introduction;
2: Reviews;
3: Naturally Occurring Amino Acids;
3.1: New Naturally Occurring Amino Acids;
4: Chemical Synthesis and Resolution of Amino Acids;
4.1: General Methods for the Synthesis of ?-Amino Acids Including Enantioselective Synthesis;
4.2: Synthesis of Protein Amino Acids and Other Naturally Occurring Amino Acids;
4.3: Synthesis of ?-Alkyl and ?-Amino Acids;
4.4: Synthesis of ?-Amino Acids with Acyclic and Long Aliphatic Side Chains;
4.5: Models for Prebiotic Synthesis of Amino Acids;
4.6: Synthesis of Halogenoalkyl ?-Amino Acids;
4.7: Synthesis of Hydroxyalkyl ?-Amino Acids;
4.8: Synthesis of N-Substituted ?-Amino Acids;
4.9: Synthesis of ?-Amino Acids carrying Unsaturated Aliphatic Side-chains;
4.10: Synthesis of ?-Amino Acids with Aromatic or Heterocyclic Side-chains;
4.11: Synthesis of ?-Amino Acids Carrying Amino Groups and Related Nitrogen Functional Groups in Aliphatic Side Chains;
4.12: Synthesis of ?-Amino Acids with Side-chains Carrying Boron Functional Groups;
4.13: Synthesis of ?-Amino Acids with Side-chain Carrying Silicon Functional Groups;
4.14: Synthesis of ?-Amino Acids with Side-chains Carrying Phosphorus Functional Groups;
4.15: Synthesis of ?-Amino Acids with Side-chains Carrying Sulfur and Selenium;
4.16: Synthesis of ?-Amino Acids with Higher Homologous Amino Acids;
4.17: Resolution of DL-Amino Acids;
5: Physico-chemical Studies of Amino Acids;
5.1: X-ray Crystal Analysis of Amino Acids and Their Derivatives;
5.2: Nuclear Magnetic Resonance Spectroscopy;
5.3: Circular Dichroism;
5.4: Mass Spectrometry;
5.5: Other Spectroscopic Studies on Amino Acids;
5.6: Measurements on Amino Acids in Solution;
5.7: Measurements on Amino Acids in the Solid State;
5.8: Amino Acids Absorption and Transport Phenomena;
5.9: Host-Guest Studies with Amino Acids;
5.10: Theoretical Calculations involving Amino Acids;
6: Reactions and Ananlysis of Amino Acids;
6.1: General and Specific Reactions of Amino Acids;
6.2: Analysis of Amino Acids;
References;
Chapter 2: Peptide Synthesis;
1: Introduction;
2: Methods;
2.1: Amino-group Protection;
2.2: Carboxy-group Protection;
2.3: Side-chain Protection;
2.4: Disulfide Bond Formation;
2.5: Peptide Bond Formation;
2.6: Peptide Synthesis on Macromolecular Supports and Methods of Combinatorial Synthesis;
2.7: Enzyme-mediated Synthesis and Semi-synthesis;
2.8: Miscellaneous Reactions Related to Peptide Synthesis;
3: Appendix: A List of Syntheses in 2002;
3.1: Natural Peptides, Proteins and Partial Sequences;
3.2: Sequential Oligo- and Poly-peptides;
3.3: Enzyme Substrates and Inhibitors;
3.4: Conformations of Synthetic Peptides;
3.5: Glycopeptides;
3.6: Phosphopeptides and Related Compounds;
3.7: Immunogenic and Immunosuppressant Peptides;
3.8: Nucleopeptides, PNAs;
3.9: Miscellaneous Peptides;
3.10: Purification Methods;
References;
Chapter 3: Analogue and Conformational Studies on Peptides, Hormones and Other Biologically Active Peptides;
1: Introduction;
2: Peptide Backbone Modifications and Peptide Mimetics;
2.1: Aza, Oxazole, Oxazoline, Triazole, Triazine and Tetrazole Peptides;
2.2: [CH=CH], [Z-CF CH], [CH(OH)-CH2], [CH(OH)-CH2-NH], retro- and retro-inverso- [NHCH(CF3)], [CH2O], retro- [CONR], [CO-N(NPht)], [O-CO-N], [CO-NR-O], [CH2NH], [CO-CH2-cyclopropyl-NH], [PO2R-N], [PO2R], [NHCO];
2.3: Rigid Amino Acid, Peptide and Turn Mimetics;
3: Cyclic Peptides;
4: Biologically Active Peptides;
4.1: Peptides Involved in Alzheimer's Disease;
4.2: Antimicrobial Peptides;
4.3: ACTH peptides;
4.4: Angiotensin II Analogues and Non-peptide Angiotensin II Receptor Ligands;
4.5: Bombesin/Neuromedin Analogues;
4.6: Bradykinin Analogues;
4.7: Cholecystokinin Analogues, Growth Hormone-Releasing Peptide and Analogues;
4.8: Integrin-Related Peptide and Non-Peptide Analogues;
4.9: LHRH and GnRH Analogues;
4.10: -MSH Analogues;
4.11: MHC Class I and II Analogues;
4.12: Neuropeptide Y (NPY) Analogues;
4.13: Opioid (Neuropeptide FF, Enkephalin, Nociceptin, Deltorphin and Dynorphin) Peptides;
4.14: Somatostatin Analogues;
4.15: Tachykinin (Substance P and Neurokinin) Analogues;
4.16: Vasopressin Analogues;
4.17: Insulins and Chemokines;
4.18: Peptide Toxins;
4.19: Miscellaneous;
5: Enzyme Inhibitors;
5.1: Aminopeptidase Inhibitors;
5.2: Calpain Inhibitors;
5.3: Carboxypeptidase Inhibitors;
5.4: Caspase Inhibitors;
5.5: Cathepsin and Other Cystein-Protease Inhibitors;
5.6: Cytomegalovirus and Rhinovirus 3C Protease Inhibitors;
5.7: Converting Enzymes and Their Inhibitors;
5.8: Elastase Inhibitors;
5.9: Farnesyltransferase Inhibitors;
5.10: HIV Protease Inhibitors;
5.11: Matrix Metalloproteinase Inhibitors;
5.12: NO-Synthase Inhibitors;
5.13: Proteasome Inhibitors;
5.14: Protein Phosphatase Inhibitors;
5.15: Renin and Other Aspartyl Proteinase Inhibitors;
5.16: Thrombin and Factor Xa Inhibitors;
5.17: Trypsin and Other Serine Protease Inhibitors;
5.18: tRNA Synthetase Inhibitors;
5.19: Miscellaneous;
6: Phage Library Leads;
7: Protein-protein Interaction Inhibitors;
7.1: SH2 and SH3 Domain Ligands;
8: Advances in Formulation/Delivery Technology;
References;
Chapter 4: Cyclic, Modified and Conjugated Peptides;
1: Introduction;
2: Cyclic Peptides;
2.1: General Considerations;
2.2: Cyclic Dipeptides (Dioxo or Diketo-piperazines);
2.3: Cyclotripeptides;
2.4: Cyclotetrapeptides;
2.5: Cyclopentapeptides;
2.6: Cyclohexapeptides;
2.7: Cycloheptapeptides;
2.8: Cyclooctapeptides;
2.9: Cyclononapeptides;
2.10: Cyclodecapeptides;
2.11: Higher Cyclic Peptides;
2.12: Peptides Containing Thiazole/Oxazole Rings;
2.13: Cyclodepsipeptides;
3: Modified and Conjugated Peptides;
3.1: Phosphopeptides;
3.2: O-Sulfated Peptides;
3.3: Glycopeptide Antibiotics;
3.4: Glycopeptides;
3.5: Lipopeptides;
4: Miscellaneous Structures;
References;
Chapter 5: Metal Complexes of Amino Acids and Peptides;
1: Introduction;
2: Amino Acid Complexes;
2.1: Synthesis and Structural Studies;
2.2: Solution Studies;
2.3: Kinetic Studies;
2.4: Synthetic, Analytical and Biomedical Applications of Amino Acid Complexes;
3: Peptide Complexes;
3.1: Synthesis and Structural Studies on Peptide Complexes;
3.2: Kinetics and Reactivity;
3.3: Solution Equilibria - Metal Ion Speciation of Peptide Complexes;
3.4: Metal Complexes of Peptides Containing Histidyl and Cysteinyl Residues;
3.5: Synthetic, Analytical and Biomedical Applications of Peptide Complexes;
References